Managed Care

Gyros Protein Technologies Introduces Gyrolab Generic Rodent ADA Kit Reagents to Support Preclinical Immunogenicity Assessment

Retrieved on: 
Thursday, May 2, 2024
Surgery, Science, Other Health, Veterinary, Nursing, Medical Supplies, Radiology, FDA, Other Science, Pharmaceutical, Diabetes, Research, Optical, Oncology, Mental Health, Medical Devices, Stem Cells, Infectious Diseases, Health Technology, Practice Management, Hospitals, Physical Therapy, Genetics, Managed Care, Fitness & Nutrition, Dental, Clinical Trials, Cardiology, Biotechnology, Alternative Medicine, AIDS, Health, Immunoglobulin G, Automation, ADAS, Safety, Pharmacokinetics, Animal, Primate, Software, Therapy, Litre, Toxicokinetics, Drug development

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® Generic Rodent Anti-Drug Antibody (ADA) Kit Reagents for the detection of circulating immune complexes of human IgG with rodent anti-human IgG.

Key Points: 
  • Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® Generic Rodent Anti-Drug Antibody (ADA) Kit Reagents for the detection of circulating immune complexes of human IgG with rodent anti-human IgG.
  • The Gyrolab Generic Rodent ADA Kit fills an industry-wide need for a generic assay solution to expedite immunogenicity assessment.
  • Following the introduction of Gyrolab Generic Cyno ADA Kit Reagents, the Gyrolab Generic Rodent ADA Kit Reagents further expand the utility of the Gyrolab platform into earlier drug screening and preclinical phases of development.
  • Mark Vossenaar, General Manager, Biopharmaceutical Development Division, Gyros Protein Technologies, commented: “The addition of the Gyrolab Generic Rodent ADA Kit Reagents to our portfolio enhances our offering of ready-to-use kits and solutions for use in drug screening and preclinical development.

Dr. Richard Awdeh, CEO of CheckedUp, Named as MM+M 2024 Pinnacle Award Honoree

Retrieved on: 
Thursday, May 2, 2024
Managed Care, General Health, Health Technology, Health, Point of care, Patient, Medicine, Validation, Multimedia, Point, POC, Condition, Growth, Nursing

CheckedUp announced that its CEO and co-founder, Dr. Richard Awdeh, has been named a 2024 Pinnacle Award honoree by Medical Marketing + Media (MM+M).

Key Points: 
  • CheckedUp announced that its CEO and co-founder, Dr. Richard Awdeh, has been named a 2024 Pinnacle Award honoree by Medical Marketing + Media (MM+M).
  • The 2024 Pinnacle Awards class includes 20 honorees, who hail from a diverse range of health-and wellness-adjacent organizations.
  • View the full release here: https://www.businesswire.com/news/home/20240502068698/en/
    “I am tremendously honored to be part of the 2024 Pinnacle Award class,” said Dr. Awdeh.
  • The Pinnacle Awards are designed to remedy that.”
    The 2024 Pinnacle Awards honorees are profiled in the May print edition of MM+M and will be celebrated at an in-person event on May 2 in New York City.

Magdiel Rodriguez, CEO of Alivi Health, Selected as Entrepreneur Of The Year® 2024 Florida Award Finalist by EY

Retrieved on: 
Thursday, May 2, 2024
Insurance, Human Resources, Professional Services, Health Insurance, Small Business, Other Health, Managed Care, Health, General Health, Courage, EY, Ernst & Young, Growth

Ernst & Young LLP (EY US) today announced that Magdiel Rodriguez, CEO of Alivi Health, was named an Entrepreneur Of The Year® 2024 Florida Award finalist.

Key Points: 
  • Ernst & Young LLP (EY US) today announced that Magdiel Rodriguez, CEO of Alivi Health, was named an Entrepreneur Of The Year® 2024 Florida Award finalist.
  • Magdiel Rodriguez was one of 22 regional entrepreneurs selected as finalists by an independent panel of judges.
  • “Being recognized as a finalist for the Entrepreneur Of The Year® 2024 Florida program is an incredible honor.
  • This recognition reflects the collective efforts of every individual within our organization,” said Magdiel Rodriguez, CEO of Alivi Heath.

Humana Inc. to Present at B of A Securities Health Care Conference 2024

Retrieved on: 
Thursday, May 2, 2024
Professional Services, Health, Insurance, Health Insurance, Managed Care, General Health, Diamond, Inc., Humana, Conference

Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, Chief Executive Officer, and Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at B of A Securities Health Care Conference on Tuesday, May 14, 2024, at 8:00 a.m. Pacific time.

Key Points: 
  • Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, Chief Executive Officer, and Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at B of A Securities Health Care Conference on Tuesday, May 14, 2024, at 8:00 a.m. Pacific time.
  • A live audio webcast of the presentation will be available via Humana’s Investor Relations page at humana.com .
  • The company suggests webcast participants sign on approximately 15 minutes in advance of the presentation to allow time to run a system test and download any free software needed for access purposes.

CareTrust REIT Announces First Quarter 2024 Operating Results

Retrieved on: 
Thursday, May 2, 2024
Commercial Building & Real Estate, Nursing, Construction & Property, Finance, REIT, Professional Services, Managed Care, Health, Asset Management, ISS, Investment, FAD, Hand, Normalization, Growth, FFO, ESG, Acquisition, ID, Bank

CareTrust REIT, Inc. (NYSE:CTRE) today reported operating results for the quarter ended March 31, 2024, as well as other recent events.

Key Points: 
  • CareTrust REIT, Inc. (NYSE:CTRE) today reported operating results for the quarter ended March 31, 2024, as well as other recent events.
  • CareTrust’s President and Chief Executive Officer, Dave Sedgwick, commented on the Company’s 2024 first quarter results.
  • On an annualized basis, the payout ratio was approximately 83% based on first quarter 2024 normalized FFO, and 78% based on normalized FAD.
  • A conference call will be held on Friday, May 3, 2024, at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time), during which CareTrust’s management will discuss first quarter 2024 results, recent developments and other matters.

RevolutionEHR Awarded on Newsweek’s World’s Best Digital Health Companies 2024 List

Retrieved on: 
Thursday, May 2, 2024
Data Management, Practice Management, Technology, Managed Care, Health, General Health, Biometrics, Optical, Apps, Applications, Software, Hospitals, Online, Statista, Roger Hawkins (drummer), Statistics, Practice management, Research, Newsweek, Optometry, Telehealth, Digital health, Treatment, Data analysis, Cryptocurrency

RevolutionEHR , the leading provider of practice management software for optometrists, has been awarded on Newsweek’s list of The World’s Best Digital Health Companies 2024.

Key Points: 
  • RevolutionEHR , the leading provider of practice management software for optometrists, has been awarded on Newsweek’s list of The World’s Best Digital Health Companies 2024.
  • The World’s Best Digital Health Companies 2024 ranking lists the top 400 companies from over 35 different countries.
  • Based on the results of the study, RevolutionEHR is ecstatic to be recognized on Newsweek’s World’s Best Digital Health Companies 2024 list.
  • “We are honored that RevolutionEHR has been recognized as a World's Best Digital Health Company,” said CEO Steve Auerbach.

TigerConnect Tops Recent G2 Spring 2024 Rankings

Retrieved on: 
Thursday, May 2, 2024
Health Technology, Data Management, Other Health, Technology, Apps, Applications, Managed Care, General Health, Medical Devices, Hospitals, Wearables, Mobile Technology, Telecommunications, Software, Internet, Health, Medical Supplies, Mobile, Wireless, HIPAA, ROI, Communication, Medicine, Organization, Fortune 500, Nursing

TigerConnect , healthcare's most trusted clinical collaboration platform, today announced its remarkable achievement of 32 badges from G2's Spring 2024 Reports , the world's largest and most trusted software marketplace.

Key Points: 
  • TigerConnect , healthcare's most trusted clinical collaboration platform, today announced its remarkable achievement of 32 badges from G2's Spring 2024 Reports , the world's largest and most trusted software marketplace.
  • Most notably, TigerConnect has been named a Leader in the Clinical Communication and Collaboration , HIPAA Compliant Messaging, and Medical Staff Scheduling categories.
  • G2 has recognized TigerConnect for its excellence based on user reviews across various categories, including ease of use, security, likelihood to recommend, and more.
  • With over 90 million buyers visiting G2 annually, including employees from Fortune 500 companies, G2 provides essential insights for software decisions.

Big Bend Hospice, Tallahassee Memorial HealthCare Partner on Transformative Approach to Transitional Care

Retrieved on: 
Thursday, May 2, 2024
Other Health, Managed Care, General Health, Radiology, Oncology, Consumer, Hospitals, Cardiology, Nursing, Seniors, Practice Management, Health, TMH, St. Joe Company, Palliative care, BBH, Hospital, Affiliation, Hospice, Partnership, Long-term care, Florida State University, Tallahassee Memorial HealthCare, Movement, Multimedia, Organization

Big Bend Hospice (BBH) and Tallahassee Memorial HealthCare (TMH) announced a partnership today to improve patient navigation within the healthcare system.

Key Points: 
  • Big Bend Hospice (BBH) and Tallahassee Memorial HealthCare (TMH) announced a partnership today to improve patient navigation within the healthcare system.
  • The signing of the Affiliation Agreement creates a governance structure that will develop a transformative approach to improving transitions of care in the Big Bend community.
  • Combining expertise allows BBH and TMH to provide a more comprehensive and patient-centered approach to healthcare across the Big Bend region.
  • “Meeting the healthcare needs of our region necessitates strategic alliances,” said Mark O’Bryant, President & CEO of Tallahassee Memorial HealthCare.

Cotiviti Completes Recapitalization with KKR and Long-Standing Owner Veritas

Retrieved on: 
Thursday, May 2, 2024
Technology, Insurance, Professional Services, Software, Other Health, Managed Care, Health, Data Analytics, Data Management, Veritas Capital, Growth, Software as a service, KKR, Renewable energy

Cotiviti, a leading healthcare data analytics and technology business, announced today the close of its business recapitalization with two premier firms, affiliates of its long-standing partner Veritas Capital (Veritas) and investment funds managed by KKR.

Key Points: 
  • Cotiviti, a leading healthcare data analytics and technology business, announced today the close of its business recapitalization with two premier firms, affiliates of its long-standing partner Veritas Capital (Veritas) and investment funds managed by KKR.
  • KKR and Veritas are now co-sponsors with equal ownership stakes in Cotiviti.
  • “In Veritas and KKR, we have two world-class investment firms joining forces because of their belief in our mission.
  • We look forward to working alongside the Cotiviti management team and Veritas to further scale the business through strategically investing in innovation, talent, and technology.”

P3 Health Partners Schedules First Quarter 2024 Earnings Release and Conference Call

Retrieved on: 
Thursday, May 2, 2024
Managed Care, Health Insurance, Health, Practice Management, P3, Webcast

The conference call will also be webcast live in the "Events & Presentations" section of the Investor page of the P3 website ( ir.p3hp.org ).

Key Points: 
  • The conference call will also be webcast live in the "Events & Presentations" section of the Investor page of the P3 website ( ir.p3hp.org ).
  • The Company’s press release will be available on the Investor page of P3’s website in advance of the conference call.
  • An archived recording of the webcast will be available on the Investor page of P3’s website for a period of 90 days following the conference call.